The aim of the European G1D Organisation is to bring together Glut1 patients and communities across Europe for mutual support.
Our two main goals are to improve the daily lives of people affected by Glut1 and to promote scientific research into this condition.
Glucose Transporter Type 1 Deficiency Syndrome is a genetic disorder that impairs brain metabolism. Glucose is not transported properly into the brain, which leaves it starving for the metabolic fuel it needs to grow, develop, and function the way it should.
Currently, the only known treatment for this condition is a ketogenic diet which is high in fat and low in carbohydrates. The ketones generated by following this diet can be used as an alternative source of fuel for the brain. This improves the symptoms and development for many patients, but is not always easy to implement and stick to.
A summary of current research and treatment recommendations for Glut1 Deficiency has been published.
Glut1 Deficiency has been assigned its own ICD-10 Code (E74.810).
A new option has been created to allow for individual membership in cases where there is a national organisation that is not a member.